
Aadrikaa Legal Services (ALS)- Law I Litigation I Arbitration
Date: 17.09.2026
Delhi High Court Sets Aside Rejection of βELMENTINβ Trademark; Says Phonetic Similarity Must Be Assessed by Look, Sound and Surrounding Circumstances
This Short Article has been prepared & written by Advocate Ravi Shekhar Jha-Delhi High Court, New Delhi. The views expressed are based on his interpretation of the law. He can be reached at his email id intelconsul@gmail.com .
The Delhi High Court has set aside the Trade Marks Registry’s refusal to register the pharmaceutical word mark βELMENTINβ, holding that it could not be regarded as phonetically similar to the earlier registered mark βELEMENTALβ merely because both marks related to medicinal and pharmaceutical products.
In Elyon Pharmaceuticals Pvt. Ltd. v. The Registrar of Trademarks, C.A.(COMM.IPD-TM) 153/2021, Justice C. Hari Shankar held that ELMENTIN and ELEMENTAL have distinctly different sounds, syllabic structures and meanings. The Court also observed that differences in the pharmaceutical composition of competing products may constitute an additional mitigating factor while assessing likelihood of confusion.
Trademark Registry Had Rejected βELMENTINβ
- Elyon Pharmaceuticals Pvt. Ltd. had filed Application No. 2668081 seeking registration of the word mark βELMENTINβ for a pharmaceutical composition containing Amoxycillin and Clavulanic Acid.
- The Examiner of Trade Marks rejected the application by an order dated August 27, 2018, invoking Section 11(1)(b) of the Trade Marks Act, 1999.
- The objection was based on an earlier registered trademark, βELEMENTALβ, registered in favour of Juggat Pharma Pvt. Ltd. for medicinal and pharmaceutical preparations in Class 5. The Registry considered ELMENTIN deceptively similar to ELEMENTAL and found a potential likelihood of confusion.
- Elyon Pharmaceuticals challenged the rejection before the Delhi High Court.
Elyon Pharmaceuticals: ELMENTIN and ELEMENTAL Sound Different
- Counsel for Elyon Pharmaceuticals argued that the two marks could not properly be regarded as phonetically similar and, therefore, the basis for refusing registration was unsustainable.
- The Registrar defended the decision, arguing that the phonetic difference between the two expressions was minimal and that ELEMENTAL already stood registered for medicinal and pharmaceutical preparations in the same class.
- After examining the rival contentions, however, the High Court disagreed with the Registry.
Delhi HC: The Two Words Have βDistinctly Different Soundsβ
- Justice Hari Shankar observed that, when properly articulated, ELMENTIN and ELEMENTAL have distinctly different sounds.
- The Court specifically noted that even the concluding syllables of the two expressions were different.
- This distinction was important because trademark similarity cannot be determined merely by identifying common letters or portions of competing marks. The marks must be considered from the perspective of their overall visual and phonetic impression and the circumstances in which consumers encounter them.
Court Applies the Classic βPianotistβ Test
- The Delhi High Court relied upon the well-established test laid down in In re Pianotist Co.’s Application, [1906] 23 RPC 774.
- Under that approach, competing marks must be assessed by considering their look and sound, the goods to which they are applied, the nature of likely consumers, the surrounding circumstances and what is likely to happen if both marks are used normally in the marketplace.
- The Court noted that the Pianotist test had received approval from the Supreme Court in Amritdhara Pharmacy v. Satya Deo Gupta, AIR 1963 SC 449, and Khoday Distilleries v. Scotch Whisky Association, (2008) 10 SCC 723.
βELMENTINβ Is a Coined Word; βELEMENTALβ Is an Ordinary English Expression
- Applying that test, the Court found substantial differences between the marks.
- βELEMENTALβ was described as a word of common English usageβan adjective associated with βelementβ and synonymous with βfundamental.β
- βELMENTIN,β on the other hand, was a coined expression having no etymological meaning.
- The Court also compared the syllabic structures. ELMENTIN contains three syllables, while ELEMENTAL contains four. Their concluding syllables were also different.
- These distinctions led the Court to conclude that it was difficult to sustain the Examiner’s finding that use of the two marks for pharmaceutical preparations was likely to confuse the public.
Coined and Arbitrary Marks Entitled to Greater Protection
- The Court further observed that ELMENTIN, being a meaningless, arbitrary and coined word, was entitled to additional trademark protection.
- For this proposition, the judgment referred to Kirorimal Kashiram Marketing & Agencies Ltd. v. Shree Sita Chawal Udyog Mill, (2010) 44 PTC 293 (DB), and South India Beverages Pvt. Ltd. v. General Mills Marketing Inc., (2015) 61 PTC 231 (DB).
- The ruling therefore reinforces the significance of invented or arbitrary terminology when examining distinctiveness and competing trademark claims.
Different Pharmaceutical Compositions Can Reduce Likelihood of Confusion
- One of the most significant observations in the judgment concerns the composition of pharmaceutical products.
- The High Court noted that the record did not establish whether the pharmaceutical composition sold under the earlier ELEMENTAL mark was the same as the composition for which Elyon Pharmaceuticals sought registration of ELMENTIN.
- Justice Hari Shankar observed that if the two pharmaceutical compositions were different, that would constitute an additional mitigating factor against the likelihood of confusion among the public.
- The observation is important because it indicates that the likelihood-of-confusion inquiry in pharmaceutical trademarks is not necessarily confined to comparing the words in isolation. The nature and composition of the underlying products may also be relevant to the overall factual assessment.
Section 11(1)(b) Rejection Set Aside
- Section 11(1)(b) of the Trade Marks Act deals with situations where similarity with an earlier trademark, coupled with identity or similarity of the relevant goods or services, creates a likelihood of confusion on the part of the public, including likelihood of association with the earlier mark.
- After applying the phonetic, visual and contextual comparison, the High Court held that the Examiner’s conclusion that ELMENTIN was disentitled to registration because of the pre-existing ELEMENTAL mark could not be sustained.
- The rejection order was accordingly set aside.
Application Remanded to Trade Marks Registry for Fresh Consideration
- Importantly, the Delhi High Court did not itself finally order registration of ELMENTIN.
- Instead, Application No. 2668081 was remitted to the concerned officer of the Trade Marks Registry for de novo consideration.
- The Registry was directed to consider the application on its own merits, but it was specifically restrained from rejecting the application on the grounds contained in Sections 11(1)(a) or 11(1)(b) of the Trade Marks Act.
- The appeal was accordingly allowed to that extent, with no order as to costs.
Cases Referred to by the Delhi High Court
The judgment expressly refers to four authorities while explaining the applicable principles of trademark comparison:
- In re Pianotist Co.’s Application, [1906] 23 RPC 774 β the classic test requiring marks to be compared by look, sound, goods, consumers and surrounding circumstances.
- Amritdhara Pharmacy v. Satya Deo Gupta, AIR 1963 SC 449 β Supreme Court approval of the Pianotist approach.
- Khoday Distilleries v. Scotch Whisky Association, (2008) 10 SCC 723 β also cited as approving the Pianotist standard.
- Kirorimal Kashiram Marketing & Agencies Ltd. v. Shree Sita Chawal Udyog Mill, (2010) 44 PTC 293 (DB), and South India Beverages Pvt. Ltd. v. General Mills Marketing Inc., (2015) 61 PTC 231 (DB) β relied upon concerning protection available to arbitrary and coined marks.
Why the Judgment Matters for Pharmaceutical Trademarks
- The ruling provides a useful framework for examination of allegedly similar pharmaceutical marks. It indicates that similarity should not be determined simply because two marks share some letters or are registered in the same class.
- Instead, the decision requires consideration of the overall appearance, pronunciation, syllabic structure, meaning, nature of the products, relevant consumers and surrounding commercial circumstances.
- It is equally important that the Court did not treat different pharmaceutical compositions as automatically eliminating confusion. Rather, it described such difference as an additional mitigating factor, meaning it forms part of the broader likelihood-of-confusion assessment.
Key Takeaway
The Delhi High Court’s ruling establishes that ELMENTIN could not be refused merely on the ground that it was allegedly phonetically similar to ELEMENTAL.
The Court found meaningful differences in sound, syllables, meaning and overall impression and set aside the Section 11(1)(b) rejection. At the same time, the judgment should not be read as a final grant of trademark registration.
The application was sent back to the Registry for fresh consideration on its own merits, subject to the Court’s direction that it could not again be rejected under Sections 11(1)(a) or 11(1)(b).
Connected Matter
Aadrikaa Legal Services is a trusted legal and regulatory support partner providing end-to-end legal solutions to law firms, corporate organizations, and businesses across India. We specialize in paralegal services, litigation support, tax and regulatory matters, delivering reliable, efficient, and result-oriented legal assistance.
Our services include comprehensive paralegal support, drafting and documentation, legal research, case management, litigation handling, and representation support across various judicial and quasi-judicial forums. We also assist in direct and indirect tax matters, customs, GST, corporate regulatory compliance, and legal advisory.
Source: Delhi High Court
Handy Download:
Write to us at office@aadrikaalaw.com
Tel: +91-11-4999 2707











